Br Med J  1968;1:335-339 (10 February), doi:10.1136/bmj.1.5588.335

Observations on recent increase in mortality from asthma.

F. E. Speizer, R. Doll, P. Heaf

The mortality attributed to asthma has increased annually in England and Wales from 1960 to 1965. The increase is more pronounced at ages 5 to 34 years than at older ages and is most pronounced at ages 10 to 14 years. In this last age group the mortality increased nearly eight times in seven years, and in 1966 asthma accounted for 7% of all deaths. No comparable increase has been observed in any other country, but smaller increases at ages 10 to 19 years have been observed in Australasia, Japan, western Europe, and the United States. There is no evidence to suggest that there has been any change in diagnostic habits, certification of deaths, or methods of classification which could account for the increase in Great Britain, and it is concluded that the increase is real. General practitioners' records provide no evidence of an increase in prevalence and it seems probable that there has been an increase in case fatality. No environmental hazards are known which could have increased the severity of the disease, and the possibility has to be considered that the increase may be due to new methods of treatment. Corticosteroids have been used increasingly since 1952, and in Great Britain the use of pressurized aerosols containing sympathomimetics has increased rapidly since 1960.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Wijesinghe, M., Weatherall, M., Perrin, K., Crane, J., Beasley, R. (2009). International Trends in Asthma Mortality Rates in the 5- to 34-Year Age Group: A Call for Closer Surveillance. Chest 135: 1045-1049 [Abstract] [Full text]  
  • Sears, M. R., Ottosson, A., Radner, F., Suissa, S. (2009). Long-acting {beta}-agonists: a review of formoterol safety data from asthma clinical trials. Eur Respir J 33: 21-32 [Abstract] [Full text]  
  • Chen, A. M, Bollmeier, S. G, Finnegan, P. M (2008). Long-Acting Bronchodilator Therapy for the Treatment of Chronic Obstructive Pulmonary Disease. The Annals of Pharmacotherapy 42: 1832-1842 [Abstract] [Full text]  
  • Wijesinghe, M, Perrin, K, Harwood, M, Weatherall, M, Beasley, R (2008). The risk of asthma mortality with inhaled long acting {beta}-agonists. Postgrad. Med. J. 84: 467-472 [Abstract] [Full text]  
  • Town, G I, Crane, J (2006). Respiratory health and lung research in New Zealand. Chronic Respiratory Disease 3: 167-169 [Abstract]  
  • Samet, J. M., Speizer, F. E. (2006). Sir Richard Doll, 1912-2005. Am J Epidemiol 164: 95-100 [Full text]  
  • Lynd, L. D., Guh, D. P., Pare, P. D., Anis, A. H. (2002). Patterns of Inhaled Asthma Medication Use: A 3-Year Longitudinal Analysis of Prescription Claims Data From British Columbia, Canada. Chest 122: 1973-1981 [Abstract] [Full text]  
  • Bernstein, I. L. (2002). {beta}2-Agonists: Deja vu All Over Again : The Second-Generation Controversy. Chest 122: 763-765 [Full text]  
  • Donahue, J. G., Weiss, S. T., Livingston, J. M., Goetsch, M. A., Greineder, D. K., Platt, R. (1997). Inhaled Steroids and the Risk of Hospitalization for Asthma. JAMA 277: 887-891 [Abstract]  
  • Speizer, F. E., Doll, R. (1987). Reappraisal of the United Kingdom Epidemic of Fatal Asthma. Arch Intern Med 147: 1853-1853 [Abstract]  
  • Esdaile, J. M., Feinstein, A. R., Horwitz, R. I. (1987). A Reappraisal of the United Kingdom Epidemic of Fatal Asthma: Can General Mortality Data Implicate a Therapeutic Agent?. Arch Intern Med 147: 543-549 [Abstract]  
  • Strunk, R. C., Mrazek, D. A., Fuhrmann, G. S. W., LaBrecque, J. F. (1985). Physiologic and Psychological Characteristics Associated With Deaths due to Asthma in Childhood: A Case-Controlled Study. JAMA 254: 1193-1198 [Abstract]  
  • Tobin, M. J. (1985). Use of Bronchodilator Aerosols. Arch Intern Med 145: 1659-1663 [Abstract]  
  • Winter, B. (1981). Bilateral Carotid Body Resection in Children with Severe Bronchial Asthma: A Retrospective Study. VASC ENDOVASCULAR SURG 15: 399-408  
  • Kinney, E. L., Trautlein, J. J., Harbaugh, C. V., Lambert, D., Zelis, R. F. (1978). Ventricular Tachycardia After Terbutaline. JAMA 240: 2247-2247 [Abstract]  
  • SHIM, C., WILLIAMS, M. H. Jr. (1975). Cardiac Response to Repeated Doses of Isoproterenol Aerosol. ANN INTERN MED 83: 208-211 [Abstract]  
  • Harris, W. S. (1973). Toxic Effects of Aerosol Propellants on the Heart. Arch Intern Med 131: 162-166 [Abstract]  
  • Sheehy, A. F., DiBenedetto, R., Lefrak, S., Lyons, H. A. (1972). Treatment of Status Asthmaticus: A Report of 70 Episodes. Arch Intern Med 130: 37-42 [Abstract]  
  • Taylor, G. J. IV, Harris, W. S. (1970). Cardiac Toxicity of Aerosol Propellants. JAMA 214: 81-85 [Abstract]  
  • (1968). Symposium on Steroids and Childhood Asthma: Steroid Therapy in Childhood Asthma?. CLIN PEDIATR 7: 439-443 [Abstract]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ